Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council Text with EEA relevance
Modified by
- Commission Delegated Regulation (EU) 2017/698of 3 February 2017amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products(Text with EEA relevance), 32017R0698, April 19, 2017
- Commission Delegated Regulation (EU) 2019/157of 6 November 2018amending Annex II to Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council(Text with EEA relevance), 32019R0157, February 1, 2019
- Commission Delegated Regulation (EU) 2019/227of 28 November 2018amending Delegated Regulation (EU) No 1062/2014 as regards certain active substances/product-type combinations for which the competent authority of the United Kingdom has been designated as the evaluating competent authority(Text with EEA relevance), 32019R0227, February 8, 2019
- Commission Delegated Regulation (EU) 2022/825of 17 March 2022amending Annex II to Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council(Text with EEA relevance), 32022R0825, May 30, 2022
Corrected by
- Corrigendum to Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council, 32014R1062R(01), July 28, 2015
(a) "non-approval decision" means a decision not to approve a substance/product-type combination pursuant to Article 9(1)(b) of Regulation (EU) No 528/2012 or to the third subparagraph of Article 89(1) of that Regulation, or not to include it in Annex I or IA to Directive 98/8/EC; (b) "substance/product-type combination included in the review programme" means a substance/product-type combination listed in Annex II which complies with the following conditions: (i) it has not been the subject of either of the following: a Directive on inclusion in Annex I or IA to Directive 98/8/EC, a Regulation providing that it is approved pursuant to the third subparagraph of Article 89(1) of Regulation (EU) No 528/2012;
(ii) it has not been the subject of any non-approval decision or the latest non-approval decision concerning it has been repealed;
(c) "participant" means a person who has submitted an application for a substance/product-type combination included in the review programme, or has submitted a notification found compliant pursuant to Article 17(5) of this Regulation, or on whose behalf such application or notification has been submitted. (d) "evaluating competent authority" means the competent authority designated pursuant to Article 81 of Regulation (EU) No 528/2012 of the Member State indicated in Annex II to this Regulation.
Loading ...